← Back to headlines
Insiders Sell Shares in Ultra Clean and Corcept
Insiders at Ultra Clean Holdings and Corcept Therapeutics have sold shares. The sales occurred after Ultra Clean reported Q1 revenue of $533.7 million and Corcept received FDA approval, leading to a $1.05 billion outlook.
12 Jul, 21:15 — 12 Jul, 21:15
Sources
Showing 1 of 1 sources
